Prognostic value of myocardial perfusion single photon emission computed tomography for major adverse cardiac cerebrovascular and renal events in patients with chronic kidney disease: results from first year of follow-up of the Gunma-CKD SPECT multicenter study

[1] Go AS(2004)Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 1296-1305

[2] Chertow GM(2003)Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community J Am Coll Cardiol 41 47-55

[3] Fan D(2004)Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies J Am Soc Nephrol 15 1307-1315

[4] McCulloch CE(2005)Health-related quality of life and estimates of utility in chronic kidney disease Kidney Int 68 2801-2808

[5] Hsu CY(2011)Diets and enteral supplements for improving outcomes in chronic kidney disease Nat Rev Nephrol 7 369-384

[6] Manjunath G(2003)Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography Circulation 107 2900-2907

[7] Tighiouart H(2011)Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy Eur Heart J 32 1012-1024

[8] Ibrahim H(2007)Prognostic value of myocardial perfusion single-photon emission computed tomography for the prediction of future cardiac events in a Japanese population: a middle-term follow-up study Circ J 71 1580-1585

[9] MacLeod B(1995)Automatic reorientation of three-dimensional, transaxial myocardial perfusion SPECT images J Nucl Med 36 1107-1114

[10] Salem DN(1995)Automatic quantification of ejection fraction from gated myocardial perfusion SPECT J Nucl Med 36 2138-2147

[1] Go AS(2004)Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 1296-1305

[2] Chertow GM(2003)Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community J Am Coll Cardiol 41 47-55

[3] Fan D(2004)Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies J Am Soc Nephrol 15 1307-1315

[4] McCulloch CE(2005)Health-related quality of life and estimates of utility in chronic kidney disease Kidney Int 68 2801-2808

[5] Hsu CY(2011)Diets and enteral supplements for improving outcomes in chronic kidney disease Nat Rev Nephrol 7 369-384

[6] Manjunath G(2003)Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography Circulation 107 2900-2907

[7] Tighiouart H(2011)Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy Eur Heart J 32 1012-1024

[8] Ibrahim H(2007)Prognostic value of myocardial perfusion single-photon emission computed tomography for the prediction of future cardiac events in a Japanese population: a middle-term follow-up study Circ J 71 1580-1585

[9] MacLeod B(1995)Automatic reorientation of three-dimensional, transaxial myocardial perfusion SPECT images J Nucl Med 36 1107-1114

[10] Salem DN(1995)Automatic quantification of ejection fraction from gated myocardial perfusion SPECT J Nucl Med 36 2138-2147